A Global Medical Device Manufacturer and A Midwest Investment Firm Expand and Increase Spend with CynergisTek’s IT Audit Group with Two Six-Figure Contracts
April 27 2022 - 11:30AM
Business Wire
CynergisTek announces its IT Audit Group expands Professional
Service agreements for a medical device manufacturer and an
investment firm
CynergisTek, Inc. (NYSE American: CTEK), leading cybersecurity,
privacy, compliance, and IT audit firm helping organizations in
highly regulated industries navigate emerging security and privacy
issues, increases its IT Audit and Privacy professional services
support for a global leader in medical device manufacturing and a
Real Estate Investment Trust (REIT) Firm located in the
Midwest.
CynergisTek has signed two contracts totaling $416k to support
both clients with professional services. There was a 37% increase
to the medical device manufacturer’s contract for expanded, ongoing
data protection and privacy risk advisory support services.
CynergisTek’s IT Audit Group has also signed a six-figure contract
with a real estate investment firm to provide IT General Computer
Control Audit services, which will provide the client with
high-level assessments of their IT system operations and security
controls, as well as recommendations for functional
improvement.
Internal audit of programs and controls is a critical component
of implementing successful privacy and security protections for
operations, systems, and data. Audit provides another set of eyes
looking at controls from an objective viewpoint. “Our IT Audit
Group, formerly known as Backbone Consultants, continues to
demonstrate its value to our clients, whether it’s conducting
independent EPCS certifications for critical systems, conducting
SOC2 or PCI readiness consulting, or, as in this case, augmenting
organizations’ internal audit teams to carry out this important
function,” said Mac McMillan, CEO of CynergisTek. “Our audit
consultants know their craft and are experts at integrating with
their customers to provide the expertise they need or additional
bandwidth to accomplish more.”
“Our IT Audit Services help clients to validate the maturity of
their IT control environment and achieve their compliance
obligations. From a privacy perspective, we also specialize in
providing our clients with expert privacy guidance to help them
maintain and manage their data responsibly and securely. As in the
case with this medical device manufacturer, organizations continue
prioritizing the management of their data and taking control of
their compliance regulations,” said Walter Zuniga, Managing Partner
of CynergisTek’s IT Audit Group.
About CynergisTek, Inc.
CynergisTek’s IT Audit Group provides clients with staff
augmentation, audit readiness consultation, and compliance
auditing, with audit services that measure them against HIPAA, SOX,
GDPR, GLBA, PCI, and general IT audit standards. CynergisTek’s IT
Audit Group also specializes in providing privacy and cybersecurity
insight to organizations in every industry sector. CynergisTek is a
top-ranked cybersecurity consulting firm helping organizations in
highly-regulated industries, including those in healthcare,
government, and finance navigate emerging security and privacy
issues. CynergisTek combines intelligence, expertise, and a
distinct methodology to validate a company's security posture and
ensure the team is rehearsed, prepared, and resilient against
threats. Since 2004, CynergisTek has been dedicated to hiring and
retaining experts who bring real-life experience and hold advanced
certifications to support and educate the industry by contributing
to relevant industry associations. For more information, visit
www.cynergistek.com or follow us on Twitter or LinkedIn.
Cautionary Note Regarding Forward Looking Statements
This release contains certain forward-looking statements
relating to the business of CynergisTek. These forward-looking
statements are within the meaning of Section 27A of the Securities
Act of 1933, as amended (the “Securities Act”) and Section 21E of
the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) and can be identified by the use of forward-looking
terminology such as “believes,” “expects,” “anticipates,” “would,”
“could,” “intends,” “may,” “will,” or similar expressions. Such
forward-looking statements involve known and unknown risks and
uncertainties, including but not limited to uncertainties relating
to product/services development; long and uncertain sales cycles;
the ability to obtain or maintain proprietary intellectual property
protection; future capital requirements; competition from other
providers; the ability of the Company’s vendors to continue
supplying the Company with supplies and services at comparable
terms and prices; the Company’s ability to successfully compete and
introduce enhancements and new features that achieve market
acceptance and that keep pace with technological developments; the
Company’s ability to maintain its brand and reputation and retain
or replace its significant customers; cybersecurity risks and risks
of damage and interruptions of information technology systems; the
Company’s ability to retain key members of management and
successfully integrate new executives; the Company’s ability to
complete acquisitions, strategic investments, entry into new lines
of business, divestitures, mergers or other transactions on
acceptable terms, or at all; potential risks and uncertainties
relating to the existing and ultimate impact of the COVID-19
pandemic, including actions that may be taken by governmental
authorities to contain the COVID-19 outbreak or to treat its
impact, and the potential negative impacts of COVID-19 on the
global economy and financial markets; the general economic impact
of the ongoing war in Ukraine, including the impact of related
sanctions being imposed by the U.S. Government and the governments
of other countries, and the impact of potential reprisals as a
consequence of the war in Ukraine and any related sanctions; and
other factors that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Certain of these risks and uncertainties are
or will be described in greater detail in the Company’s Form 10-K
and Form 10-Q filings with the Securities and Exchange Commission,
which are available at http://www.sec.gov. Given the risks and
uncertainties, readers should not place undue reliance on any
forward-looking statement and should recognize that the statements
are predictions of future results which may not occur as
anticipated. Many of the risks listed above have been, and may
further be, exacerbated by the COVID-19 pandemic, including its
impact on the healthcare industry, or the ongoing war in Ukraine.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the risks and uncertainties described herein, as well as others not
now anticipated. CynergisTek is under no obligation (and expressly
disclaims any such obligation) to update or alter its
forward-looking statements whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220427005800/en/
CynergisTek Investor Relations Contact: CynergisTek, Inc.
Bryan Flynn (512) 402-8550 x7 InvestorRelations@cynergistek.com
CynergisTek Media Contact: CynergisTek, Inc. Trinity
McPherson (443) 853-8468 trinity.mcpherson@cynergistek.com
CynergisTek (AMEX:CTEK)
Historical Stock Chart
From Mar 2024 to Apr 2024
CynergisTek (AMEX:CTEK)
Historical Stock Chart
From Apr 2023 to Apr 2024